{
  "docId": "019de075-2875-74d4-8194-84b6aaf5cb83",
  "docSlug": "17078b9c485724b1d98591e3cd98aa3e",
  "documentTitle": "Kymera | Investor Presentation Deck | 60 slides",
  "authorId": "kymera",
  "authorName": "Kymera",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 60,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a split-layout with a company profile on the left and a list of key accomplishments on the right.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-2875-74d4-8194-84b6aaf5cb83/3",
  "deckHref": "/decks/019de075-2875-74d4-8194-84b6aaf5cb83",
  "deckJsonHref": "/decks/019de075-2875-74d4-8194-84b6aaf5cb83.json",
  "deckAnchorHref": "/decks/019de075-2875-74d4-8194-84b6aaf5cb83#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.58,
        "x": 0.38,
        "y": 0.0027
      },
      "kind": "list",
      "text": "Advanced four programs to clinical stage. Developed a deep pipeline positioned to deliver ≥1 IND/year. First to advance degrader (KT-474/SAR444656) in healthy volunteers and patients with HS and AD. Demonstrated degrader vs. small molecule inhibitors (SMI) biological and clinical differentiation, and potential best in class profile in I/I. Demonstrated fidelity of translation of PK, PD and safety across three clinical programs in I/I and oncology patients. Unique target selection strategy based on using TPD to unlock high value, undrugged targets. Well-capitalized with $516m of cash, enabling expansion of clinical impact into areas with large clinical and commercial opportunities.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aefb02e5-7c62-448d-8b7a-b7f7fdf5b7bf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.3,
        "x": 0.05,
        "y": 0.0038
      },
      "kind": "paragraph",
      "text": "Recognized leader in Targeted Protein Degradation (TPD). Building a fully-integrated, global biotech company. Initial I/I and Oncology focus, but a disease-agnostic platform. Accelerating forward integration through key strategic partnerships.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9d30d7d6-0faa-4d43-8e15-fdcb9971fca7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.134,
        "x": 0.433,
        "y": 0.04
      },
      "kind": "title",
      "text": "Overview",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b13a0696-0dca-432c-8404-64bb39df5b85",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.4,
        "x": 0.51,
        "y": 0.00175
      },
      "kind": "title",
      "text": "Key Accomplishments",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d34d45cf-5475-437d-9943-2863df1b8ed0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "31222f0c-39cc-4bfd-af3c-304b38655b5f",
      "evidence": "This slide is an executive summary as it provides a high-level overview of the company's accomplishments and goals.",
      "confidence": 0.9
    },
    {
      "name": "Storytelling: the three headline reasons",
      "slug": "three-reasons",
      "agent": "storyteller",
      "layer": "slide",
      "matchId": "7a1a2ecf-fade-471a-b85a-a167f53b6589",
      "evidence": "The slide presents several key accomplishments, which can be considered as three main reasons for the company's success.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}